Novartis secures EC approval for up-titration of Cosentyx for ankylosing spondylitis
Cosentyx is supported by sufficient clinical evidence, including 5-year data across PsO, PsA and AS, along with data…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Oct 19
Cosentyx is supported by sufficient clinical evidence, including 5-year data across PsO, PsA and AS, along with data…
About 2,000 people die in the UK each year from taking powerful painkillers - and overprescriptions are a…
23 Oct 19
Biorphen avoids the compounding and reduces the risks for unsafe injection practices, medication administration errors, sterility breaches, and…
The global rate of drug discovery has been in decline since the 1950s, but pharma company AstraZeneca is…
22 Oct 19
The transaction is expected to be completed in the first quarter of 2020 and is subject to customary…
21 Oct 19
The previous phase 2 study of MOB-015 showed the delivery of high microgram levels of terbinafine into the…
21 Oct 19
FDA approval of ULTOMIRIS based on data from two global, single-arm open-label studies of ULTOMIRIS, separately in adults…
18 Oct 19
The study results demonstrated that Xofluza has reduced the time required to improve from flu symptoms compared to…
17 Oct 19
The transaction is expected to close in the first half of 2020, subject to the approval of Achillion…
Healx has raised $56m in Series B funding to aid its AI-powered drug discovery mission. NS Healthcare caught…